Understanding AusUDID: Australia’s Unique Device Identification Database

Over the last decade, Unique Device Identification (UDI) systems have reshaped how medical devices are tracked worldwide. The United States introduced GUDID,the European Union launched EUDAMED, and Switzerland followed with swissdamed. 

All of these systems are built on the same principle: devices in scope must have a unique, standardized identifier on its label, and that identifier needs to be registered in a central database. When safety issues arise, regulators, hospitals, and manufacturers must be able to identify the exact device quickly and accurately. 

AusUDID is Australia’s contribution to this global infrastructure.

If your company supplies medical devices or in vitro diagnostic (IVD) devices to the Australian market, AusUDID is becoming a critical part of your regulatory landscape.

What is AusUDID?

AusUDID stands for the Australian Unique Device Identification Database. It is the national UDI database operated by the Therapeutic Goods Administration (TGA). Its purpose is straightforward: it stores UDI Device Identifiers (UDI-DIs) and related reference data for medical devices and IVDs supplied in Australia.

The database is public and searchable. Healthcare professionals, sponsors, regulators, and even patients can look up device information. This shared visibility supports:

• Recall management 
• Adverse event investigations 
• Implant tracking 
• Registry reporting 
• Supply chain verification 

In short, AusUDID ensures that everyone is referring to the same device in the same way. 

Key Data Elements Within AusUDID

Manufacturers assign Unique Device Identifications (UDIs) to their medical devices. This is a fixed code that identifies a specific device model and packaging level, and is stored in AusUDID. The UDI-DI standard is developed by recognized issuing agencies, such as GS1 (using the GTIN), HIBCC & ICCBBA. AusUDID also records structured reference data. These data elements are aligned with the international standards of IMDRF but tailored to Australian regulatory requirements.

The UDI-DI can be issued by recognized issuing agencies, such as GS1, and is typically encoded as a GTIN or similar identifier. In addition to the UDI-DI, AusUDID records structured reference data. These data elements are aligned with international standards but tailored to Australian regulatory requirements. 

Key data elements of AusUDID 

• Device Identifier (UDI-DI): The unique code identifying a device model and its packaging level. Different packaging configurations may have different DIs.
• Sponsor Details: An Australian sponsor is the legal entity responsible for supplying a device in Australia. Sponsor details are captured as sponsor-specific data elements (alongside device data), including sponsor identification information and ARTG linkage where applicable. The sponsor is accountable for submitting and maintaining accurate data in AusUDID.
• Brand Name and Model Information: The trade name and version or model number exactly as shown on the label. This allows healthcare providers to match database information with the physical product.
• GMDN Code and Term: The Global Medical Device Nomenclature (GMDN) code defines the device type. This supports regulatory grouping and post-market surveillance activities.
• Links to ARTG Entries: Each UDI-DI record is linked to the corresponding ARTG (Australian Register of Therapeutic Goods) inclusion. This connection confirms that the device is authorized for supply in Australia.

Learn more about how these data elements relate with the global UDI regulations, in the dedicated osapiens UDI guide. 

Key stakeholders within AusUDID

Manufacturers 

Responsible for assigning the UDI, having a quality management system, and may provide device information to AusUDID on behalf of the sponsors.

Sponsors 

Sponsors are responsible for submitting and maintaining UDI records for applicable devices. They link ARTG details to UDI records (which makes the UDI records publicly available) and manage supporting documents to UDI records.

Healthcare professionals and hospitals 

Clinicians and hospital procurement teams can verify device details, confirm models, and check supply status. This supports inventory management, implant documentation, and recall verification.

Regulators 

The TGA uses AusUDID data to monitor device performance, manage recalls, and detect safety signals. The structured data improves consistency in post-market surveillance.

Public 

Basic device information is publicly accessible. Patients can confirm implant details or verify sponsor information.

For manufacturers, this means that data quality directly affects how your device is represented and perceived in the Australian market. 

AusUDID implementation timelines and what to expect

The TGA is rolling out UDI requirements through a phased, risk-based approach. The most urgent deadline applies to higher-risk devices. 

From July 1, 2026, manufacturers and sponsors of Class III and Class IIb medical devices, including implantables, must: 

• Apply UDI carriers to labels and packaging, and 
• submit corresponding UDI-DIs to the AusUDID Production database. 

Lower-risk classes will follow in later phases. IVD devices have separate timelines extending from 2028 to 2030. 

Regulatory deadlines move faster than internal projects 

Although July 2026 may seem far, UDI implementation is rarely a quick project. Many companies operating globally assume their existing UDI data can simply be reused. In practice, differences in sponsor roles, ARTG linkages, and local requirements mean that each local regulation demands focused attention. 

Therefore, it is important to treat AusUDID as a separate, structured compliance project. 

Take the Next Step Toward AusUDID Readiness 

AusUDID is part of a broader shift toward standardized device traceability and regulatory transparency. If your organization supplies medical devices to the Australian market, now is the time to evaluate your readiness. 

The osapiens HUB for Medical Devices enables manufacturers to manage and validate all device and UDI information in a central, secure and fully validated environment. The solution supports early testing, ensures high data quality and integrates seamlessly with the global database.  

If you are assessing your AusUDID readiness, understanding the operational implications is the next step. 

Join our practical compliance readiness webinar to learn: 

• What steps to take now 
• How to prepare your data and labeling processes 
• Common implementation challenges and how to avoid them 
• What July 2026 means for your portfolio 

Secure your spot and ensure your AusUDID strategy is aligned before deadlines take effect.